During the past decade, Ospedal SS Annunziata conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ospedal SS Annunziata" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials, followed by "Medtronic" with 3 trials sponsored, "Fondazione Italiana Linfomi ONLUS" with 2 trials sponsored, "Gruppo di Ricerca GISSI" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedal SS Annunziata" #1 collaborator was "Acute Leukemia French Association" with 1 trials as a collaborator, "Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte" with 1 trials as a collaborator and "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ospedal SS Annunziata" are "Heart Failure" (4 trials), "Leukemia" (4 trials), "Atrial Fibrillation" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials) and "Diffuse Large B-cell Lymphoma" (1 trials). Many other conditions were trialed in "Ospedal SS Annunziata" in a lesser frequency.

Most popular intervention types in "Ospedal SS Annunziata" are "Drug" (8 trials), "Procedure" (6 trials), "Radiation" (4 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "mitoxantrone hydrochloride" (4 trials), "radiation therapy" (4 trials), "Placebo" (3 trials), "allogeneic bone marrow transplantation" (3 trials) and "autologous bone marrow transplantation" (3 trials). Other intervention names were less common.

The vast majority of trials in "Ospedal SS Annunziata" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Ospedal SS Annunziata". undefined are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ospedal SS Annunziata, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedal SS Annunziata, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".